Wed, May 22, 8:11 PM (245 days ago)
The Oncology Institute, Inc. filed an Amendment No. 1 to its Form 10-Q for the quarter ending March 31, 2024. This amendment addresses the omission of specific language in the certifications required by Section 302 of the Sarbanes-Oxley Act of 2002. The missing language pertains to internal control over financial reporting. No other information from the original filing, submitted on May 14, 2024, has been altered or updated. The amendment should be reviewed in conjunction with the original filing and other SEC submissions. As of May 7, 2024, the company had 74,437,924 shares of common stock outstanding.